Close menu
Science Library Category:

Inflammation

Differential immune responses and microbiota profiles in children with autism spectrum disorders and co-morbid gastrointestinal symptoms
Published: 2018
SYNOPSIS

Autistic children with gastrointestinal symptoms have an imbalance in their immune response that affects behavior and quality of life.

CITATION

Rose DR, Yang H, Serena G, Sturgeon C, Ma B, Careaga M, Hughes HK, Angkustsiri K, Rose M, Hertz-Picciotto I, Van de Water J, Hansen RL, Ravel J, Fasano A, Ashwood P. Brain, Behavior, and Immunity. 2018;70:354-368.

SUMMARY

Children with autism spectrum disorder (ASD) and concurrent gastrointestinal (GI) symptoms have a more imbalanced immune response, a more disturbed gut microbiome and worse behavioral outcomes (such as irritability, agitation, social withdrawal, lethargy, hyperactivity and noncompliance) than ASD children without GI symptoms. The study additionally looked at typically developing children with and without GI symptoms and found that ASD+GI children stood out compared to those two groups as well. Children with ASD plus GI symptoms may have a “propensity” toward leaky gut that contributes to their other symptoms and clinical outcomes.

View Abstract

Vaccines and neuroinflammation
Published: 2018
SYNOPSIS

Vaccination can trigger a series of cascading events that disturbs the balance between “protective immunity” and “destructive inflammation.”

Citation

Giannotta G, Giannotta N. International Journal of Public Health & Safety. 2018;3:3.

 

Summary

This study explores molecular mechanisms capable of explaining “post-vaccination inflammatory syndrome” and the neuroinflammation observed in children with autism. Focusing especially on vaccines (such as HPV vaccines) that contain biopersistent aluminum adjuvants, the authors describe how “continuously escalating doses of this poorly biodegradable adjuvant…may become insidiously unsafe,” especially in children who are vaccinated repeatedly or who have an immature or altered blood-brain barrier. Vaccination can trigger a series of cascading events (involving overexpression of the signaling molecules that regulate inflammation and activation of brain cells called microglia) that disturbs the balance between “protective immunity” and “destructive inflammation.”

View Abstract

Selective accumulation of aluminum in cerebral arteries in Alzheimer’s disease (AD)
Published: 2013
SYNOPSIS

Researchers found higher accumulations of aluminum in the brains of patients with Alzheimer’s disease.

CITATION

Bhattacharjee S, Zhao Y, Hill JM, … Lukiw WJ. Journal of Inorganic Biochemistry. 2013;126:35–37.

SUMMARY

To improve understanding of a pathological aluminum entry system into the brain, this study examined the aluminum content of eight arteries that supply blood to the hippocampus, including the aorta and several cerebral arteries. In contrast to age-matched controls, AD patients exhibited a gradient of increasing aluminum concentration from the aorta to the posterior cerebral artery that supplies blood to the hippocampus.

View Abstract

Mechanisms of aluminum adjuvant toxicity and autoimmunity in pediatric populations
Published: 2012
SYNOPSIS

Canadian researchers review literature on autoimmunity and neurological risks from vaccine adjuvant aluminum, express doubts regarding safety testing.

CITATION

L Tomljenovic, CA Shaw. Lupus. 2012;21:223–230.

SUMMARY

“Immune challenges during early development, including those vaccine-induced, can lead to permanent detrimental alterations of the brain and immune function. Experimental evidence also shows that simultaneous administration of as little as two to three immune adjuvants can overcome genetic resistance to autoimmunity. In spite of the widespread agreement that vaccines are largely safe and serious adverse complications are extremely rare, a close scrutiny of the scientific literature does not support this view. For example, to date, the clinical trials that could adequately address vaccine safety issues have not been conducted (i.e., comparing health outcomes in vaccinated versus non-vaccinated children). Infants and young children should not be viewed as ‘small adults.’ Their unique physiology makes them much more vulnerable to noxious environmental insults in comparison with the adult population. In spite of this, children are routinely exposed to much higher levels of Al vaccine adjuvants than adults, even though adequate safety data on these compounds are lacking. That Al vaccine adjuvants can induce significant autoimmune conditions in humans can hardly be disputed, although still debatable is how common such side effects are. However, the existing data (or lack thereof) raise questions on whether the current vaccines aimed at pediatric populations can be accepted as having adequate safety profiles. Because infants and children represent those who may be most at risk for complications following vaccination, a more rigorous evaluation of potential vaccine-related adverse health impacts in pediatric populations than what has been provided to date is urgently needed.”

View Abstract

Genetic Basis for Adverse Events Following Smallpox Vaccination
Published: 2008
SYNOPSIS

Three gene variations are associated with adverse reactions to smallpox vaccination.  

CITATION

Reif DM, McKinney BA, Motsinger AA, Chanock SJ, Edwards KM, Rock MT, Moore JH, Crowe Jr. JE. Genetic basis for adverse events following smallpox vaccination. The Journal of Infectious Diseases. 2008;198(1):16-22.

SUMMARY

A pair of NIH-funded studies identified three genetic variations that make people more susceptible to systemic adverse events following smallpox vaccination. By studying the smallpox vaccine, the researchers focused on a vaccine historically noted for frequently causing adverse reactions in population-wide vaccination programs. In the two studies, 16/96 and 24/46 individuals experienced systemic adverse events after vaccination, and three candidate genes (MTHFR, IRF1 and IL4) had the strongest association with the adverse events. In susceptible individuals, “vaccination appears to trigger an acute inflammatory response that is excessive.”

View Abstract